Related Experiment Video
Updated: Jun 21, 2026

Retroperitoneal Laparoscopic Debridement and Drainage for Pancreatic Abscess
Published on: March 15, 2024
Antimicrobial management of intra-abdominal infections
1Unita Operativa di Malattie Infettive, Policlinico Borgo Roma G B Rossi, Verona, Italy.
Abstract:
Antimicrobial therapy of intra-abdominal infection must be based on its etiology, which is generally polymicrobial, and its location, with the aim of selecting the most suitable antimicrobial agents not only according to their spectrum but also their pharmacokinetic profile. Currently, both monotherapy and combination therapy can be used, thanks to the availability of newer drugs characterized by a wide range of antimicrobial activity against both aerobes and anaerobes. Antibiotic choice and duration of therapy also vary according to the severity of the infection.
Insights
Effective antimicrobial therapy for intra-abdominal infections requires considering the polymicrobial cause and infection site. Treatment choice, including monotherapy or combination therapy, depends on drug spectrum, pharmacokinetics, and infection severity.
Area of Science:
- Infectious Diseases
- Pharmacology
Background:
- Intra-abdominal infections (IAIs) are typically polymicrobial, necessitating careful antimicrobial selection.
- Treatment strategies must account for both the causative pathogens and the infection's anatomical location.
Purpose of the Study:
- To outline the principles for selecting appropriate antimicrobial agents for intra-abdominal infections.
- To discuss the role of monotherapy versus combination therapy in managing IAIs.
Main Methods:
- Review of current antimicrobial agents and their pharmacokinetic profiles.
- Consideration of pathogen spectrum, including aerobic and anaerobic coverage.
- Assessment of infection severity to guide treatment decisions.
Main Results:
- Newer antimicrobial drugs offer broad-spectrum activity against both aerobic and anaerobic bacteria.
- Both monotherapy and combination therapy are viable options for IAI treatment.
- Antimicrobial selection and treatment duration are influenced by infection severity.
Conclusions:
- Optimal antimicrobial therapy for IAIs hinges on etiology, location, spectrum of activity, and pharmacokinetics.
- The choice between monotherapy and combination therapy should be individualized based on clinical factors.
- Tailoring antibiotic selection and duration to infection severity is crucial for successful outcomes.
Related Concept Videos
Urinary Tract Infection IV: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Urine Studies II: Urine Culture and Sensitivity Test
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...